The International MAOI Expert Group unites clinicians and researchers with specific expertise in the pharmacology and clinical use of the classic monoamine oxidase inhibitor (MAOI) antidepressants (phenelzine, tranylcypromine, isocarboxazid). The Group has recently authored two Prescriber’s Guides o...See more
Headquarter Australia |
Countries of operation Australia |
Year founded 2022 (2 years) |
Funding status Private |
Company type SME |
Chairman